Analysis
DEEP FOCUS: Everything you need to know about Spotify (SPOT) stock
Spotify (NYSE: SPOT) stock has recovered 38% since late December when it touched a new 52-week low of $103. However,…
Abbvie’s oncology push makes it an attractive stock
Abbvie (NYSE: ABBV) is one of the worse performing pharma stocks in the trailing 12-month period. The stock has declined…
Top biotech stocks to be considered for investment this year
When the massive selloff battered Wall Street in the final months of 2018, biotechnology stocks were no exception. And, most…
Rating downgrade of Lam Research dampens recovery hopes; stock dips 4%
The recovery of Lam Research (LRCX) from last year’s lows had received a boost after the latest earnings report but…
Top 5 tech M&A announcements so far in 2019
The technology sector is fast evolving with new start-ups offering innovative services popping up on a regular basis. While acquisitions…
LightPath Technologies stock dips to 4-year low
LightPath Technologies (NASDAQ: LPTH) stock fell to a 4-year low of $0.94 on Monday as investors remained concerned about the…
These deals set a new paradigm for healthcare industry
After a busy 2018, the scale of merger and acquisition activity in the healthcare industry is expected to be high…
Facebook – Will the giant fall or not?
Facebook (NYSE: FB) is in the middle of a storm right now with anti-trust probes and even calls for a…